NYU Langone Health Names Alec C. Kimmelman, MD, PhD, as Next CEO and Dean
Renowned Radiation Oncologist and Director of Laura and Isaac Perlmutter Cancer Center, Dr. Kimmelman will succeed retiring CEO and Dean Robert I. Grossman, MD, on September 1
Using Big Data to Connect Medical Education & Patient Care
NYU School of Medicine has analyzed vast data sets to determine how its medical-training curriculum impacts patient outcomes in the real world.
Zoster Eye Disease Study (ZEDS) Results
... importance of result, need to focus on clinical meaningfulness 10 DC 01242025 Valacyclovir Treatment Benefit ...
2018 Grant Awards | NYU Langone Health
A number of NYU Langone Judith and Steward Colton Center pilot projects received grant funding in 2018.
Researcher Seeks to Understand Cancer Metastasis Mechanisms
Dr. Amanda W. Lund, a member of NYU Langone’s Perlmutter Cancer Center, studies how T cells decide to stay or exit from tumor cells.
Biostatistics Symposium Agenda NYU 2024
... . In this paper, we analyze event studies from the perspective of experimental design and focus on the use ... training in Epidemiology at Columbia University, with a focus in epidemiologic methods and causal inference ...
Head & Neck Cancer Doctors Help People Look Better
Head and neck cancer doctors at NYU Langone Health’s Perlmutter Cancer Center provide people with cancer the best quality of life possible.
Hematologist Provides Complete Care for People with Leukemia
Dr. Mohammad Maher Abdul Hay, a hematologist at NYU Langone’s Perlmutter Cancer Center, works to advance treatments for people with leukemia.
Innovative Treatments for Advanced Colorectal Cancer
Dr. Bashar A. Safar, a surgical oncologist at NYU Langone’s Perlmutter Cancer Center, specializes in treating advanced colorectal cancer.
NYU Langone Health in the News—February 11, 2025
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from February 11, 2025.